Suchergebnisse - "Xia, Zhongjun"

PubPharm (12)

1

Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients : Multi-center, single-arm, open-label, phase 2 study

enthalten in: American journal of hematology | 2023

von Xu, W. | Zhou, K. | Wang, T. | +22

2

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China : a retrospective multicenter study

enthalten in: Cancer biology & medicine | 2023

von Fan, H. | Wang, W. | Zhang, Y. | +6

3

Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma : A multicenter study

enthalten in: Cancer medicine | 2022

von Zhang, Y. | Liu, P. | Cai, J. | +19

4

Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming

enthalten in: Molecular cancer | 2022

von Liang, Y. | He, H. | Wang, W. | +7

5

Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH) : a phase II, single-arm study

enthalten in: BMC medicine | 2022

von Qiu, L. | Xia, Z. | Fu, C. | +20

6

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

enthalten in: EMBO molecular medicine | 2022

von Zhou, Q. | Liang, J. | Yang, T. | +14

7

Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma : A multicenter study

enthalten in: American journal of hematology | 2021

von Zhang, Y. | Ma, S. | Cai, J. | +17

8

A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era : a multi-institutional cohort study

enthalten in: British journal of cancer | 2021

von Cai, J. | Tian, X. | Ma, S. | +15

9

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

enthalten in: BMC cancer | 2016

von Sun, Y. | Cheng, Y. | Hao, X. | +16

10

High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type

enthalten in: Annals of hematology | 2015

von Wang, H. | Li, P. | Wang, L. | +4